Clinical Trials Directory

Trials / Conditions / Non-Small Cell Lung Carcinoma (NSCLC)

Non-Small Cell Lung Carcinoma (NSCLC)

11 registered clinical trials studyying Non-Small Cell Lung Carcinoma (NSCLC) — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingImpact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable Muta
NCT07369596
University of Malaya—
RecruitingA Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.
NCT07362459
Sinocelltech Ltd.Phase 3
WithdrawnA Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positiv
NCT04460729
Novartis PharmaceuticalsPhase 2
CompletedRelative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairme
NCT04256707
Karyopharm Therapeutics IncPhase 1 / Phase 2
TerminatedLITT and Pembrolizumab in Recurrent Brain Metastasis
NCT04187872
University of FloridaPhase 1
Active Not RecruitingStudy of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)
NCT03003962
AstraZenecaPhase 3
Active Not RecruitingStudy of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer
NCT02542293
AstraZenecaPhase 3
Active Not RecruitingPhase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SO
NCT02453282
AstraZenecaPhase 3
CompletedImproving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Ed
NCT02558998
Abramson Cancer Center at Penn MedicineN/A
TerminatedStudy of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected A
NCT02346955
Famewave Ltd.Phase 1
CompletedZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung
NCT00328562
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 1